Navigation Links
IMPAX Presents at Movement Disorder Society's 11th International,Congress of Parkinson's Disease and Movement Disorders

.com.

"Safe Harbor" statement under the Private Securities Litigation Reform Act of 1995:

To the extent any statements made in this news release contain information that is not historical, these statements are forward-looking in nature and express the beliefs and expectations of management. Such statements are based on current expectations and involve a number of known and unknown risks and uncertainties that could cause IMPAX's future results, performance or achievements to differ significantly from the results, performance or achievements expressed or implied by such forward-looking statements. Such risks and uncertainties include, but are not limited to, possible adverse effects resulting from the delisting of and suspension of trading in IMPAX's stock, the SEC proceeding to determine whether to suspend or revoke the registration of IMPAX's securities under section 12 of the Securities Exchange Act, IMPAX's delay in filing its periodic reports subsequent to its Form 10-Q for the third quarter of 2004, IMPAX's ability to obtain sufficient capital to fund its operations, the difficulty of predicting FDA filings and approvals, consumer acceptance and demand for new pharmaceutical products, the impact of competitive products and pricing, IMPAX's ability to successfully develop and commercialize pharmaceutical products, IMPAX's reliance on key strategic alliances, the uncertainty of patent litigation, the availability of raw materials, the regulatory environment, dependence on patent and other protection for innovative products, exposure to product liability claims, fluctuations in operating results and other risks detailed from time to time in IMPAX's filings with the Securities and Exchange Commission. Forward-looking statements speak only as to the date on which they are made, and IMPAX undertakes no obligation to update publicly or revise any forward-looking statement, regardless of whether new information becomes available, future developments occur
'"/>




Page: 1 2 3 4

Related medicine technology :

1. Inspiration Biopharmaceuticals Presents Data From Hemophilia Program at International Society On Thrombosis and Haemostasis (ISTH) Annual Meeting
2. European Society for Medical Oncology (ESMO) Presents Data from the Clinical Trial of MediGenes Cancer-Killing Virus in Press Conference
3. Cytogen Presents Phase 1 Data Showing Promising Antitumor Activity and Safety Profile of Quadramet at International Myeloma Workshop
4. SemBioSys Presents Positive Insulin Data at the American Diabetes Association Conference
5. Tranzyme Pharma Presents Initial Phase IIa Data for its Novel Ghrelin Agonist, TZP-101, in Patients with Diabetic Gastroparesis
6. Novagali Pharma Presents at AACO the Results of its Pivotal Phase III Clinical Trial of Vekacia in Children Suffering From Vernal Keratoconjunctivitis
7. BioLife Solutions Presents Data on CryoStor at International Society for Cellular Therapy Annual Meeting
8. Genaera Presents Preclinical Data on Trodusquemine (MSI-1436) for the Treatment of Obesity at the American Diabetes Association 67th Scientific Session
9. Elixir Pharmaceuticals Presents Preclinical Data Highlighting Its Ghrelin Antagonist Program at the American Diabetes Associations Annual Meeting
10. DiObex Presents Phase 2a Data of DIO-902 Demonstrating Trends of Improved Glycemic Control and Significant Reductions of LDL-Cholesterol and C-Reactive Protein
11. BioCryst Presents Phase I Peramivir Data at the Options for the Control of Influenza Conference

Post Your Comments:
(Date:11/9/2009)..., BATESVILLE, Ind. and MCDONOUGH, Ga., Nov. 9 /PR...d Encompass Group today announced the formation of...istribution of a comprehensive range of surface re...arate from a bed frame and as replacements for sur...end of their useful life. Hill-Rom, a global lead...
(Date:11/9/2009)..., ,, PRINCETON, N.J., Nov. 9 /PRNewswire...nnounces management will present at the Sixth Annu...he conference will be held at the St Regis Hotel i...efer Price, Pharmasset,s President and Chief Execu...any on Wednesday, November 18, 2009 at 3:45 PM (ET...
(Date:11/9/2009)..., HOUSTON, Nov. 9 Patent attorne...tipkala, Ph.D., J. D., will showcase Stipkala LLC ...3, 2009, which will be held at the Institute of Mo...cience Conference provides a platform for cutting-...ties to investors, and will feature keynote addres...
Breaking Medicine Technology:Hill-Rom and Encompass Group Form Joint Venture 2Hill-Rom and Encompass Group Form Joint Venture 3Hill-Rom and Encompass Group Form Joint Venture 4Hill-Rom and Encompass Group Form Joint Venture 5Pharmasset to Present at Lazard Capital Markets Healthcare Conference 2Pharmasset to Present at Lazard Capital Markets Healthcare Conference 3Feel Fun Fit 26 Fabulous 21 At the 2009 Womens Health Conference 52117 1Feel Fun Fit 26 Fabulous 21 At the 2009 Womens Health Conference 52117 2Feel Fun Fit 26 Fabulous 21 At the 2009 Womens Health Conference 52117 3Our brain looks at eyes first to identify a face 9280 1Our brain looks at eyes first to identify a face 9280 2Our brain looks at eyes first to identify a face 9280 3Scholarships Available for PA Breast Cancer Coalition Annual Conference 52115 1Scholarships Available for PA Breast Cancer Coalition Annual Conference 52115 2
...,Contributing Editor , ,Positive patient ide...editing bodies for the past few years. Until rece...are were beyond the reach of the average hospital ...ith devices that can be integrated into a facility...ter for small facilities, while others are best fo...
...vard Medical School ,Contributing Editor , ,...per year, breast cancer undoubtedly qualifies as o...ntly, efforts to develop early detection methods a...ress. This is particularly true at the molecular ...e translated into new diagnostic tests and targete...
Other Medicine Technology:Managing Preanalytical Processes for Patient Safety 2Managing Preanalytical Processes for Patient Safety 3Managing Preanalytical Processes for Patient Safety 4Breast Cancer and HER-2/neu: Diagnostic Tools for Targeted Therapy 2Breast Cancer and HER-2/neu: Diagnostic Tools for Targeted Therapy 3
(Date:11/9/2009)...GTON, Nov. 9 The Churchill Centr...d For Leadership to J.W. "Bill" Marriott for his l...progressive free market practices and fostering an... Marriott will receive his award at a ceremony and...D.C. Four Seasons Hotel. ,, "This is a testame...
(Date:11/9/2009)...e left atrial enlargement, study finds , ... major risk factor for left atrial enlargement, wh...oke and death, a new study shows. , Atrial fibr... irregular heart rhythm or heartbeat). , Resea...25 to 74, in Germany who were followed for 10 year...
(Date:11/9/2009)...due to fact that both eye conditions are age-relat...HealthDay News) -- Cataract surgery doesn,t appear...egeneration (AMD), according to a new study that c...sion loss worsens the other. , "Because both co...s with cataract also have AMD," wrote Li Ming Dong...
(Date:11/9/2009)...are increases with longer doctor visits, researche...s) -- Family doctors are now taking more time cons... and improving the quality of visits, a new study ...r primary care physicians during office visits in ...erall they seemed to receive better care," said Dr...
(Date:11/9/2009)... Course, to be Offered in April 2010,... , Cambridge, MA (Vocus) ...ans for Human Rights (PHR) first inspected a suspe... he realized he would need a team of experts to he...he site properly was a key first step in securing ...
Breaking Medicine News(10 mins):Health News:J.W. 'Bill' Marriott to Receive Churchill Centre Award For Leadership 2Health News:Cataract Surgery Doesn't Worsen Macular Degeneration: Study 2Health News:Doctors Spending More Time Now With Patients 2Health News:Doctors Spending More Time Now With Patients 3Health News:Physicians for Human Rights Offers Training in Crime Scene Documentation 2Health News:Physicians for Human Rights Offers Training in Crime Scene Documentation 3Health News:Physicians for Human Rights Offers Training in Crime Scene Documentation 4
...n worms are shedding new light on the hormone,s ro...lthDay News) -- Scientists have gained new insight...the groundwork for an anti-aging treatment. , The...s whose insulin levels were adjusted lived a week ...
...nati, OH March 20, 2008 In workplaces where nurs...es, the health of nurses suffers, and the retentio...le published in the Journal of Obstetric, Gynecolo... environment. , More than half of nurses surveye...
...gton, DC, March 20, 2008 -- The Association for Pr...(APIC) today announced a detailed strategy to comb.... The initiative begins with the first national pr...rrhea and more serious intestinal conditions such ...
...as appeared among Hispanic Enterprise,s best compa...nce 2005, COLUMBUS, Ga., March 20 Aflac Incorpor... supplier diversity list by Hispanic,Enterprise ma...ase and are,committed to the economic prosperity i...
... March 20, 2008 A bodysuit that heats or cools a...ye movements, is providing multiple sclerosis rese...ew tool to study the mysterious link between body ...ho reported in 1889 that some people have temporar...
...PARK, Kan., March 20 A recent outbreak of,Eastern...rong reminder to,horse owners throughout the count...r dangerous mosquito-borne diseases. To ensure you...at protects,against West Nile virus, EEE and Weste...
Other Medicine News:Health News:Tweaking Insulin Might Help Fight Aging 2Health News:APIC launches first national C. difficile prevalence study 2Health News:Aflac Named Among the 50 Best Companies for Supplier Diversity 2Health News:Eye test peers into heat-related multiple sclerosis symptoms 2Health News:Fort Dodge's 'Mosquito Shot' Offers Convenient Protection Against Dangerous Mosquito-Borne Illnesses 2
Thyroglobulin Autoantibody - ELISA
Coat-a-Count Estradiol RIA
... the quantitative determination of Estradiol (E2) ...(E2) is a C18 steroid hormone with a phenolic A ri...f 272.4. It is the most potent natural Estrogen, ...ller amounts by the adrenal cortex, and the male t...
AxSYM Troponin-I ADV
Medicine Products: